Cvi Holdings, LLC Vascular Biogenics Ltd. Transaction History

Cvi Holdings, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.12 - $1.63 $203,714 - $296,477	-181,888 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.96 - $1.57 $466,429 - $762,806	-485,864 Reduced 72.76%	181,888 $246,000
Q4 2019 Feb 14, 2020	SELL	$1.1 - $1.32 $171,997 - $206,396	-156,361 Reduced 18.97%	667,752 $801,000
Q3 2019 Nov 14, 2019	SELL	$1.11 - $1.42 $93,969 - $120,212	-84,657 Reduced 9.32%	824,113 $1.11 Million
Q2 2019 Aug 14, 2019	SELL	$1.16 - $1.53 $214,917 - $283,469	-185,274 Reduced 16.93%	908,770 $1.18 Million
Q1 2019 May 15, 2019	SELL	$0.94 - $1.75 $289,269 - $538,534	-307,734 Reduced 21.95%	1,094,044 $1.66 Million
Q4 2018 Feb 14, 2019	SELL	$0.6 - $1.72 $202,990 - $581,906	-338,318 Reduced 19.44%	1,401,778 $1.36 Million
Q3 2018 Nov 14, 2018	SELL	$1.55 - $2.17 $243,049 - $340,269	-156,806 Reduced 8.27%	1,740,096 $2.83 Million
Q2 2018 Aug 14, 2018	BUY	$2.05 - $3.0 $3.89 Million - $5.69 Million	1,896,902 New	1,896,902 $4.17 Million

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.